Skip to main content
Veterinary Medicines

Gentamicin BREMER PHARMA 50 mg/ml šķīdums injekcijām liellopiem, suņiem un kaķiem

Authorised
  • Gentamicin

Product identification

Medicine name:
Gentamicin BREMER PHARMA 50 mg/ml šķīdums injekcijām liellopiem, suņiem un kaķiem
Active substance:
  • Gentamicin
Target species:
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Gentamicin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        228
        day
      • Milk
        7
        day
    • Dog
    • Cat
  • Intravenous use
    • Cattle
      • Meat and offal
        228
        day
      • Milk
        7
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB03
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bremer Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bremer Pharma GmbH
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/95/0336
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."